TELA Bio, Inc.
TELA- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001561921
In the last 90 days, TELA Bio, Inc. insiders filed 4 open-market purchases and 0 sales; 45 institutions reported holding it in 13F filings for Q2 2026, worth $19.3M in total; no superinvestor holds it.
Holders of 5% or more of TELA
Holders whose latest Schedule 13D or 13G filing reports 5% or more of TELA Bio, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Ew Healthcare Partners Fund 2, L.P. | 13D | 17.23%7.71M shares | −0.09 ppfrom 17.32% | Feb 18, 202112 filings | Jun 9, 2026 | SEC |
| Nantahala Capital Management, LLC | 13G/A | 12.94%5.79M shares | +0.04 ppfrom 12.90% | Nov 14, 20244 filings | Aug 14, 2026 | SEC |
| North Run Capital, LP | 13G/A | 9.30%3.68M shares | +4.30 ppfrom 5.00% | May 30, 20252 filings | May 30, 2025 | SEC |
| Stonepine Capital Management, LLC | 13G/A | 6.00%2.35M shares | – | Oct 29, 20242 filings | Feb 13, 2025 | SEC |
| Lytton Laurence W | 13G/A | 5.50%2.44M shares | −1.70 ppfrom 7.20% | Jul 22, 20245 filings | May 15, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
53 Schedule 13D and 13G filings on TELA Bio, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Feb 18, 2021 | Ew Healthcare Partners Fund 2, L.P. | 13DOld format | – | New | – | SEC |
| Feb 12, 2021 | RTW Investments, LP | 13G/AOld format | – | – | – | SEC |
| Jan 26, 2021 | Quaker BioVentures II LP | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
2 notices from officers, directors and other affiliates planning to sell TELA Bio, Inc. shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Jun 28, 20245:37 PM ET | OrbiMed Private Investments IV, LPShareholder | 428.4K | $2.20M | Jun 28, 2024 | Themis Trading LLC | SEC |
| Apr 19, 20237:55 PM ET | OrbiMed Private Investments IV, LPShareholder | 192.0K | $2.04M | Apr 19, 2023 | Themis Trading LLC | SEC |